Lumida
/CL
⌘K
Colgate-Palmolive Co

Colgate-Palmolive Co

CL
$86.80USD-1.25%-1.10 today

MARKET CAP

69.2B

P/E (TTM)

23.0x

FWD P/E

21.7x

DAY RANGE

$86 – $91

52W RANGE

$75
$99

AI Summary

Stalk
TrimMedium

CL is in a Stage 4 distribution phase, having decisively broken below the prior cluster and 200-day SMA on a wide red candle (Support Failure), indicating buyers are overwhelmed and further downside can accelerate. Short-term momentum is extended—price is below the sloping EMAs and RSI/Options score show extreme oversold—so execution should be deferred into any rallies or tests of broken support rather than initiating new sells at current extension.

  • Q4 2025 organic sales +3% driven by Brazil and India
  • Q1 2026 revenue of $4.1B, up 6% YoY on emerging markets strength
  • Negative earnings yield indicates potential overvaluation
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$17.4B$18.0B$19.5B$20.1B$20.4B
YoY %+5.8%+3.1%+8.3%+3.3%+1.4%
P / Sales4.2x3.7x3.4x3.7x3.1x
EV / Sales4.9x4.5x4.2x4.4x3.9x
Gross Profit, Adj.$10.4B$10.2B$11.3B$12.2B$12.3B
YoY %+3.6%-1.2%+10.5%+7.4%+0.7%
Margin %59.6%57.0%58.2%60.5%60.1%
EV / Gross Profit8.3x7.9x7.2x7.3x6.4x
EBITDA, Adj.$4.5B$4.2B$4.6B$4.9B$4.9B
YoY %+0.8%-6.7%+9.4%+7.1%-0.4%
Margin %25.6%23.1%23.4%24.2%23.8%
EV / EBITDA19.2x19.4x17.9x18.3x16.2x
EBIT$3.3B$2.9B$4.0B$4.3B$3.3B
YoY %-14.2%-13.2%+37.7%+7.1%-22.5%
Margin %19.1%16.1%20.5%21.2%16.2%
EV / EBIT25.7x27.8x20.4x20.9x23.8x
Net Income$2.2B$1.8B$2.3B$2.9B$2.1B
YoY %-19.6%-17.6%+28.9%+25.6%-26.2%
Net Margin12.4%9.9%11.8%14.4%10.5%
EPS (GAAP)$2.55$2.13$2.77$3.51$2.63
YoY %-18.8%-16.5%+30.0%+26.7%-25.1%